Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,618 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Unmet clinical needs in chronic spontaneous urticaria. A GA²LEN task force report.
Maurer M, Weller K, Bindslev-Jensen C, Giménez-Arnau A, Bousquet PJ, Bousquet J, Canonica GW, Church MK, Godse KV, Grattan CE, Greaves MW, Hide M, Kalogeromitros D, Kaplan AP, Saini SS, Zhu XJ, Zuberbier T. Maurer M, et al. Among authors: bousquet pj, bousquet j. Allergy. 2011 Mar;66(3):317-30. doi: 10.1111/j.1398-9995.2010.02496.x. Epub 2010 Nov 17. Allergy. 2011. PMID: 21083565 Review.
The clinical safety of H1-receptor antagonists. An EAACI position paper.
Passalacqua G, Bousquet J, Bachert C, Church MK, Bindsley-Jensen C, Nagy L, Szemere P, Davies RJ, Durham SR, Horak F, Kontou-Fili K, Malling HJ, van Cauwenberge P, Canonica GW. Passalacqua G, et al. Among authors: bousquet j. Allergy. 1996 Oct;51(10):666-75. doi: 10.1111/j.1398-9995.1996.tb02109.x. Allergy. 1996. PMID: 8904993 Review. No abstract available.
Local immunotherapy.
Malling HJ, Abreu-Nogueira J, Alvarez-Cuesta E, Björkstén B, Bousquet J, Caillot D, Canonica GW, Passalacqua G, Saxonis-Papageorgiou P, Valovirta E. Malling HJ, et al. Among authors: bousquet j. Allergy. 1998 Oct;53(10):933-44. doi: 10.1111/j.1398-9995.1998.tb03793.x. Allergy. 1998. PMID: 9821472 Review. No abstract available.
Consensus statement on the treatment of allergic rhinitis. European Academy of Allergology and Clinical Immunology.
van Cauwenberge P, Bachert C, Passalacqua G, Bousquet J, Canonica GW, Durham SR, Fokkens WJ, Howarth PH, Lund V, Malling HJ, Mygind N, Passali D, Scadding GK, Wang DY. van Cauwenberge P, et al. Among authors: bousquet j. Allergy. 2000 Feb;55(2):116-34. doi: 10.1034/j.1398-9995.2000.00526.x. Allergy. 2000. PMID: 10726726 No abstract available.
Benefits of omalizumab as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE.
Humbert M, Beasley R, Ayres J, Slavin R, Hébert J, Bousquet J, Beeh KM, Ramos S, Canonica GW, Hedgecock S, Fox H, Blogg M, Surrey K. Humbert M, et al. Among authors: bousquet j. Allergy. 2005 Mar;60(3):309-16. doi: 10.1111/j.1398-9995.2004.00772.x. Allergy. 2005. PMID: 15679715 Clinical Trial.
1,618 results